Neurogene (Neurogene) Machinery, Furniture, Equipment : $0.29 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Neurogene Machinery, Furniture, Equipment?

Neurogene's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2024 was $0.29 Mil.

Neurogene's quarterly Machinery, Furniture, Equipment stayed the same from Sep. 2023 ($0.29 Mil) to Dec. 2023 ($0.29 Mil) and stayed the same from Dec. 2023 ($0.29 Mil) to Mar. 2024 ($0.29 Mil).

Neurogene's annual Machinery, Furniture, Equipment increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.29 Mil) but then declined from Dec. 2022 ($0.29 Mil) to Dec. 2023 ($0.29 Mil).

Neurogene Machinery, Furniture, Equipment Historical Data

The historical data trend for Neurogene's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Machinery, Furniture, Equipment Chart

Neurogene Annual Data

Trend

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

0.29

Neurogene Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Machinery, Furniture, Equipment	Get a 7-Day Free Trial			-	0.29	0.29	0.29	0.29

Neurogene Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Neurogene (Neurogene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

535 W 24th Street, 5th Floor, New York, NY, USA, 10011

Website

https://www.neurogene.com

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines

From GuruFocus

Neurogene Announces Business Update and 2024 Outlook

By Business Wire • 01-05-2024

Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million

By Business Wire • 12-19-2023